{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T21:10:26Z","timestamp":1741986626471,"version":"3.38.0"},"publisher-location":"Boston, MA","reference-count":44,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461357544"},{"type":"electronic","value":"9781461518570"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995]]},"DOI":"10.1007\/978-1-4615-1857-0_6","type":"book-chapter","created":{"date-parts":[[2011,12,4]],"date-time":"2011-12-04T00:07:49Z","timestamp":1322957269000},"page":"29-46","source":"Crossref","is-referenced-by-count":5,"title":["Neurotoxicity of MPTP and Uptake of MPPT into Dopamine and Norepinephrine Neurons in Mice"],"prefix":"10.1007","author":[{"given":"Eminy H. Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. T.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0006-8993(90)90576-W","volume":"515","author":"N Arai","year":"1990","unstructured":"Arai, N., Misugi, K., Goshima, Y. and Misu, Y.: Evaluation of a l-methyl-4-phenyl-1, 2, 3, 6-tetra-hydropyridine (MPTP)-treated C57 black mouse model for parkinsonism. Brain Res. 515: 57\u201363, 1990.","journal-title":"Brain Res."},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"RS Burns","year":"1983","unstructured":"Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobwitz, D. M. and Kopin, I. J.: A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Proc. Natl. Acad. Sci. U. S. A. 80: 4546\u20134550, 1983.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0304-3940(90)90614-F","volume":"118","author":"KJ Campbell","year":"1990","unstructured":"Campbell, K. J., Takada, M. and Hattori, T.: Evidence for retrograde axonal transport of MPP+ in the rat. Neurosci. Lett. 118: 151\u2013154, 1990.","journal-title":"Neurosci. Lett."},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0361-9230(93)90215-W","volume":"31","author":"FW Chang","year":"1993","unstructured":"Chang, F. W., Wang, S. D., Lu, K. T. and Lee, E. H. Y.: Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB\/c mice. Brain Res. Bull. 31: 253\u2013266, 1993.","journal-title":"Brain Res. Bull."},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/0006-291X(85)91071-X","volume":"128","author":"K Chiba","year":"1985","unstructured":"Chiba, K., Trevor, A. J. and Castagnoli, N., Jr.: Activie uptake of MPP+, a metabolite of MPTP, by brain synaptosomes. Biochem. Biophys. Res. Commun. 128: 1228\u20131232, 1985.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"6_CR6","first-page":"893","volume":"44","author":"CC Chiueh","year":"1985","unstructured":"Chiueh, C. C., Johannessen, J. N., Chesselet, M. F. and Markey, S. P.: Neurotoxic mechanism of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) and its oxidative metabolites in the nigrostriatal system of C57BL6 mice. Fed. Proc. 44: 893, 1985.","journal-title":"Fed. Proc."},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0892-0362(90)90061-G","volume":"12","author":"VA Colotla","year":"1990","unstructured":"Colotla, V. A., Flores, E., Oscos, A., Meneses, A. and Tapia, R.: Effects of MPTP on locomotor activity in mice. Neurotoxicol. Teratol. 12: 405\u2013407, 1990.","journal-title":"Neurotoxicol. Teratol."},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ana.410200403","volume":"20","author":"LS Forno","year":"1986","unstructured":"Forno, L. S., Langston, J. W., Delanney, L. E., Irwin, I. and Ricaurte, G. A.: Locus ceruleus lesions and eosinophilicinclusions in MPTP-treated mondeys. Ann. Neurol. 20: 449\u2013455, 1986.","journal-title":"Ann. Neurol."},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0922-4106(91)90073-Q","volume":"208","author":"M Gerlach","year":"1991","unstructured":"Gerlach, M., Riederer, P., Przuntek, H. and Youdim, B. H.: MPTP mechanisms of neurotoxic-ity and their implications for parkinson\u2019s disease. Eur. J. Pharmacol.208: 273\u2013286, 1991.","journal-title":"Eur. J. Pharmacol."},{"key":"6_CR10","first-page":"79","volume":"96","author":"EG Gray","year":"1962","unstructured":"Gray, E.G. and Whittaker, V. P.: The isolation of nerve endings from brain: an electron microscopic study of cell fragments divided by homogenization and centrifugation. J. Anat.96: 79\u201388, 1962.","journal-title":"J. Anat."},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1126\/science.242074","volume":"190","author":"PM Groves","year":"1975","unstructured":"Groves, P. M.. Wilson, C. J., Young, S. J. and Rebec, G. V.: Self-inhibition by dopaminergic neurons. Science, 190: 522\u2013529, 1975.","journal-title":"Science"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0361-9230(84)90234-X","volume":"13","author":"M Gupta","year":"1984","unstructured":"Gupta, M., Felten, D. L. and Gash, D. M.: MPTP alters central catecholamine neurons in addition to the nigrostriatal system. Brain Res. Bull. 13: 737\u2013742, 1984.","journal-title":"Brain Res. Bull."},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1471-4159.1985.tb07120.x","volume":"44","author":"H Hallman","year":"1985","unstructured":"Hallman, H., Lange, J., Olson, L., Stromberg, I. and Jonsson, G.: Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine on brain catecholamine neurons in the mouse. J. Neurochem. 44: 117\u2013127, 1985.","journal-title":"J. Neurochem."},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1126\/science.6610213","volume":"224","author":"RE Heikkila","year":"1984","unstructured":"Heikkila, R. E., Hess, A. and Duvoisin. R. C.: Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in mice. Science (Wash. DC) 224: 1451\u20131453, 1984a.","journal-title":"Science (Wash. DC)"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/311467a0","volume":"311","author":"RE Heikkila","year":"1984","unstructured":"Heikkila, R. E., Manzino, L., Cabbat, F. S. and Duvoisin, R. C.: Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine by monoamine oxidase inhibitors. Nature (Lond.) 311: 467\u2013469, 1984b.","journal-title":"Nature (Lond.)"},{"key":"6_CR16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0022-3565(25)20417-7","volume":"259","author":"SC Hu","year":"1991","unstructured":"Hu, S. C., Chang, F. W., Sung, Y. J., Hsu, W. M. and Lee, E. H. Y.: Neurotoxic effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the substantia nigra and the locus coeruleus in BALB\/c mice. J. Pharmacol. Exp. Ther. 259: 1379\u20131387, 1991.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/syn.890050204","volume":"5","author":"MF Jarvis","year":"1990","unstructured":"Jarvis, M. F.and Wagner, G. C.: 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity in the rat; characterization and age-dependent effects. SYNAPSE, 5: 104\u2013112, 1990.","journal-title":"SYNAPSE"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","volume":"82","author":"JA Javitch","year":"1985","unstructured":"Javitch. J. A., D\u2019Amato, R. J., Strittmatter, S. M. and Snyder, S. H.: Parkinsonism-induc-ing neurotoxin, N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. U. S.A. 82: 2173\u20132177, 1985.","journal-title":"Proc. Natl. Acad. Sci. U. S.A."},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0304-3940(84)90467-1","volume":"50","author":"P Jenner","year":"1984","unstructured":"Jenner, P., Rupniak, N. M. J., Rose, S., Kelly, E., Kilpatrick, G., Less, A. and Marsden, C. D.: 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neurosci. Lett. 50: 85\u201390, 1984.","journal-title":"Neurosci. Lett."},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0197-0186(90)90109-7","volume":"16","author":"T Kuriyama","year":"1990","unstructured":"Kuriyama, T., Taguchi, J. I. and Kuriyama, K.: Functional alterations in striatal cholinergic and striatonigral gabaergic neurons following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) administration. Neurochem. Int. 16: 319\u2013329, 1990.","journal-title":"Neurochem. Int."},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","volume":"292","author":"JW Langston","year":"1984","unstructured":"Langston, J. W., Forno, L. S., Rebert, C. S. and Irwin, I. 1-methyl-1, 2, 5, 6-tetrahydropyridine causes selective damage to the zona compacta of the substantia nigra in the squirrel monkey. Brain Res. 292: 390\u2013394, 1984.","journal-title":"Brain Res."},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0031-9384(88)90267-3","volume":"42","author":"EHY Lee","year":"1987","unstructured":"Lee, E. H. Y., Lin, Y. P. and Yin, T. H.: Effects of lateral and medial septal lesions on various activity and reactivity measures in rats. Physiol. Behave. 42: 97\u2013102, 1987.","journal-title":"Physiol. Behave."},{"key":"6_CR23","unstructured":"Lehmann, A.: Atlas stereotaxique du cerveau de la souris. 1974."},{"key":"6_CR24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265\u2013275, 1951.","journal-title":"J. Biol. Chem."},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2990.1983.tb00320.x","volume":"9","author":"DMA Mann","year":"1983","unstructured":"Mann, D. M. A. and Yates, P. O.: Pathological basis for neurotransmitter changes in Parkinson\u2019s disease. Neuropathol. Appl. Neurobiol. 9: 3\u201319, 1983.","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"6_CR26","first-page":"1","volume":"2","author":"DMA Mann","year":"1983","unstructured":"Mann, D. M. A. Yates, P. O. and Hawkes, J.: The pathology of thehuman locus ceruleus. Clin. Neuropathol. 2: 1\u20137, 1983.","journal-title":"Clin. Neuropathol."},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0028-3908(86)90247-9","volume":"25","author":"LA Matsuda","year":"1986","unstructured":"Matsuda, L. A., Schmidt, C. J., Hanson, G. R. and Gibb, J. W.: Effect of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat. Neuropharmacology, 25: 249\u2013255, 1986.","journal-title":"Neuropharmacology"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0304-3940(85)90424-0","volume":"61","author":"IJ Mitchell","year":"1985","unstructured":"Mitchell, I. J., Cross, A. J., Sambrook, M. A. and Crossman, A. R.: Sites of the neurotoxic action of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus. Neurosci. Lett. 61: 195\u2013200, 1985.","journal-title":"Neurosci. Lett."},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1471-4159.1989.tb01863.x","volume":"52","author":"H Nissbrandt","year":"1989","unstructured":"Nissbrandt, H., Sundstrom, E., Jonsson, G., Hjorth, S. and Carlsson, A.: Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacta, pars reticulata, and striatum. J. Neurochem. 52: 1170\u20131182, 1989.","journal-title":"J. Neurochem."},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0003-2697(83)90375-5","volume":"128","author":"MA Peat","year":"1983","unstructured":"Peat, M. A. and Gibb, J. W.: High performance liquid Chromatographic determination of indoleamines, dopamine and norepinephrine in rat brain with fluorimetric detection. Anal. Biochem. 128: 275\u2013280, 1983.","journal-title":"Anal. Biochem."},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0304-3940(87)90543-X","volume":"75","author":"BR Ransom","year":"1987","unstructured":"Ransom, B. R., Kunis, D. M., Irwin, I. and Langston, J. W.: Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+. Neurosci. Lett. 75: 323\u2013328, 1987.","journal-title":"Neurosci. Lett."},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/00207458909002162","volume":"48","author":"WGJ Reid","year":"1989","unstructured":"Reid, W. G. J., Broe, G. A., Hely, M. A., Morris, J. G. L., Williamson, P. M., O\u2019Sullivan, D. J., Rail, D., Genge, S. and Moss, N. G.: The neuropsychology of de novo patients with age on onset. Int. J. Neurosci. 48: 205\u2013217, 1989.","journal-title":"Int. J. Neurosci."},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0304-3940(85)90141-7","volume":"59","author":"GA Ricaurte","year":"1985","unstructured":"Ricaurte, G. A., Langston, J. W., Delanney, L. E., Irwin, I. and Brooks, J. D.: Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the mouse striatum. Neurosci. Lett. 59: 259\u2013264, 1985.","journal-title":"Neurosci. Lett."},{"key":"6_CR34","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1523\/JNEUROSCI.11-07-02209.1991","volume":"11","author":"GS Robertson","year":"1991","unstructured":"Robertson, G. S., Damsma, G. and Fibiger, H. C.: Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J. Neurosci. 11: 2209\u20132216, 1991.","journal-title":"J. Neurosci."},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0006-8993(74)90395-3","volume":"68","author":"DS Segal","year":"1974","unstructured":"Segal, D. S. and Kuczenski, R.: Tyrosine hydroxylase activity: Regional and subcellular distribution in brain. Brain Res. 68: 261\u2013266, 1974.","journal-title":"Brain Res."},{"key":"6_CR36","volume-title":"Nonparametric Statistics for the Behavioral Science","author":"M Siegel","year":"1965","unstructured":"Siegel, M.: Nonparametric Statistics for the Behavioral Science, McGraw-Hill Company, New York, 1965."},{"key":"6_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(90)81315-F","volume":"274","author":"T. P. Singer","year":"1990","unstructured":"Singer, T. P. and Ramsay, R. R.: Mechanism of the neurotoxicityof MPTP. FEBS Lett. 274: 1-8, 1990.","journal-title":"FEBS Lett."},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0006-8993(90)91656-2","volume":"528","author":"E Sundstrom","year":"1990","unstructured":"Sundstrom, E., Fredriksson, A. and Archer, T.: Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL\/6 mice: A model for Parkinson\u2019s disease. Brain Res. 528: 181\u2013188, 1990.","journal-title":"Brain Res."},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0006-8993(75)90276-0","volume":"92","author":"TH Svensson","year":"1975","unstructured":"Svensson, T. H., Bunney, B. S. and Aghajanian, G. K.: Inhibition of both noradrenergic and serotonergic neurons in brain by the a-adrenergic agonist clonidine. Brain Res. 92: 291\u2013306, 1975.","journal-title":"Brain Res."},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0304-3940(87)90623-9","volume":"78","author":"M Takada","year":"1987","unstructured":"Takada, M., Li, Z. K. and Hattori, T.: Intracerebral MPTP injections in the rat cause cell loss in the substantia nigra, ventral tegmental area and dorsal raphe. Neurosci. Lett. 78: 145\u2013150, 1987.","journal-title":"Neurosci. Lett."},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1212\/WNL.42.2.407","volume":"42","author":"JW Tetrud","year":"1992","unstructured":"Tetrud J. W. and Langston, J. W.: Tremor in MPTP-induced parkinsonism. Neurology,42: 407\u2013410, 1992.","journal-title":"Neurology"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0301-0082(81)90005-8","volume":"17","author":"VPAM Dognen Van","year":"1981","unstructured":"Van Dognen, V. P. A. M.: The human locus coeruleus in neurology and psychiatry (Parkinson\u2019s, Lewy body, Hallervorden-Spatz, Alzheimer\u2019s and Korsakoff s disease, (pre) senile dementia, schizophrenia, affective disorders, psychosis). Prog. Neurobiol. 17: 97\u2013139, 1981.","journal-title":"Prog. Neurobiol."},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1471-4159.1989.tb09165.x","volume":"52","author":"J Willoughby","year":"1989","unstructured":"Willoughby, J., Cowburn, R. F., Hardy, J. A., Glover, V. and Sandler, M.: 1-Methyl-4-phenylpyridine uptake by human and rat striatal synaptosomes. J. Neurochem. 52: 627\u2013631, 198","journal-title":"J. Neurochem."},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0304-3940(90)90733-P","volume":"108","author":"JA Wilson","year":"1990","unstructured":"Wilson, J. A., Doyle, T. J. and Lau, Y. S.: MPTP, MPDP+ and MPP+ cause decreases in dopamine content in mouse brain slices. Neurosci. Lett. 108: 213\u2013218, 1990.","journal-title":"Neurosci. Lett."}],"container-title":["Advances in Experimental Medicine and Biology","Neurochemistry in Clinical Application"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-1857-0_6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:49:29Z","timestamp":1741985369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-1857-0_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"ISBN":["9781461357544","9781461518570"],"references-count":44,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-1857-0_6","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1995]]}}}